Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.35 +0.21 (1.73%)
Previous Close $12.14    52 Week High $30.40 
Open $12.50    52 Week Low $11.86 
Day High $12.65    P/E N/A 
Day Low $12.17    EPS $0.00 
Volume 2,819,485